[go: up one dir, main page]

AU4249297A - Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma - Google Patents

Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma

Info

Publication number
AU4249297A
AU4249297A AU42492/97A AU4249297A AU4249297A AU 4249297 A AU4249297 A AU 4249297A AU 42492/97 A AU42492/97 A AU 42492/97A AU 4249297 A AU4249297 A AU 4249297A AU 4249297 A AU4249297 A AU 4249297A
Authority
AU
Australia
Prior art keywords
glaucoma
treatment
compositions containing
receptor agonist
ht1a receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42492/97A
Inventor
Louis DeSantis Jr
Neville Osborne
Verney Sallee
Najam Sharif
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU4249297A publication Critical patent/AU4249297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU42492/97A 1996-10-31 1997-09-04 Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma Abandoned AU4249297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2879096P 1996-10-31 1996-10-31
US60028790 1996-10-31
PCT/US1997/015542 WO1998018458A1 (en) 1996-10-31 1997-09-04 Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma

Publications (1)

Publication Number Publication Date
AU4249297A true AU4249297A (en) 1998-05-22

Family

ID=21845446

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42492/97A Abandoned AU4249297A (en) 1996-10-31 1997-09-04 Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma

Country Status (2)

Country Link
AU (1) AU4249297A (en)
WO (1) WO1998018458A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
CN1269484C (en) * 1998-09-18 2006-08-16 艾尔科实验室公司 Serotonergic 5HT2 agonists for treating glaucoma
PT1187611E (en) 1999-06-03 2004-10-29 Maxim Pharm Inc HISTAMINE OPHTHALMIC COMPOSITIONS AND UTILIZATIONS
US20030207890A1 (en) 2001-02-23 2003-11-06 Collier Robert J Compounds with 5-ht1a activity useful for treating disorders of the outer retina
JP2003527423A (en) * 2000-03-17 2003-09-16 アルコン、インコーポレイテッド Compounds having 5-HT2 and 5-HT1A agonist activity for treating glaucoma
WO2002098860A1 (en) 2001-06-01 2002-12-12 Alcon, Inc. Novel fused indazoles and indoles and their use for the treatment of glaucoma
CN100384417C (en) 2001-06-01 2008-04-30 艾尔科公司 Pyranoindazoles and use thereof for preparing medicament for treating glaucoma
JP2004534781A (en) 2001-06-01 2004-11-18 アルコン，インコーポレイテッド Novel arylaminopropane analogs and their use in treating glaucoma
US6884816B2 (en) * 2001-08-31 2005-04-26 Alcon, Inc. Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
MXPA05006277A (en) 2002-12-13 2005-09-08 Alcon Inc Novel benzopyran analogs and their use for the treatment of glaucoma.
JP2004262812A (en) * 2003-02-28 2004-09-24 Rohto Pharmaceut Co Ltd Ocular hypotensive
US7476687B2 (en) 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
TW200520760A (en) 2003-12-15 2005-07-01 Alcon Inc Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
WO2006062839A1 (en) 2004-12-08 2006-06-15 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667068B1 (en) * 1990-09-26 1994-09-09 Adir NOVEL HETEROCYCLIC ALKYL AMINES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US5229387A (en) * 1991-09-20 1993-07-20 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives
US5998467A (en) * 1995-10-25 1999-12-07 Mitsubishi Chemical Corporation Medicine for oculopathy

Also Published As

Publication number Publication date
WO1998018458A1 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
AU4249297A (en) Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma
EP0813410A4 (en) SUBSTITUTED N-ARYLMETHYL AND HETEROCYCLYLMETHYL-1H-PYRAZOLO 3,4-b]QUINOLIN-4-AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
EP0828485A4 (en) Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
AU4244596A (en) Fluorocarbon containing coatings, compositions and methods of use
AU3497295A (en) Compositions and methods for the treatment of body weight disorders, including obesity
AU2349395A (en) Morpholine derivatives and their use as antagonists of tachikinins
NZ302926A (en) Composition for use as antihistamines comprising piperidinoalkanol derivatives and inert ingredients
AU4462093A (en) Viscoelastic personal care composition
AU3102097A (en) Spiro-piperidine derivatives and their use as therapeutic agents
GB2327190B (en) Process for the preparation of depilatory compositions and their use
HUP0101475A3 (en) 4,5,6 and 7-indole and indoline derivatives, their preparation and use
AU4018897A (en) Novel 3,4-diaryloxazolone derivatives, methods of preparation and therapeutic uses thereof
CA2347863A1 (en) Treatment of disorders of the outer retina
AU3268197A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU1753892A (en) Mammalian gap-43 compositions and methods of use
AU9068398A (en) 3-substituted 3,4,5,7-tetrahydro-pyrrolo3',4':4,5 thieno2,3-dpyrimidine derivatives, their preparation and use as 5ht antagonists
IL126022A (en) Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in the preparation of pharmaceutical composition for treating depressive disorders and bipolar disorders
AU6714996A (en) 2-(fluorenonyl)-carbapenems, compositions and methods of use
AU4994996A (en) Composition for the treatment of diarrhea, its use and its preparation
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
AU2289495A (en) Dihydropyrimidine dehydrogenase compositions and methods of use
SG45105A1 (en) Uses and compositions of difluoromethoxy-2,2,2- trifluoroethane
IL139962A0 (en) 4,5,6 and 7-indole and indoline derivatives, their preparation and use
AU6824396A (en) Melatonin derivatives and their use in cosmetic or dermopharmaceutical compositions